Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-08-16

FDA Approved: KETOROLAC TROMETHAMINE — Original Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved an Original Application for Ketorolac Tromethamine injectable product from Chartwell RX, LLC (ANDA210616). It represents the approval of a generic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac tromethamine (Ketorolac tromethamine)

Snippet

ORIG AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)